Prevention of vascular calcification: is pyrophosphate therapy a solution?
Veerle P Persy, Marc D McKee
Index: Kidney Int. 79(5) , 490-3, (2011)
Full Text: HTML
Abstract
Pyrophosphate, a ubiquitous small-molecule inhibitor of mineralization abundantly present in the extracellular environment, binds to calcium and mineral surfaces to inhibit crystal growth. O'Neill and colleagues show in uremic rats that systemic administration of pyrophosphate prevents or reduces uremia-related vascular calcification, without overt negative consequences for bone and without calcium pyrophosphate deposition disease. These findings prompt further research into the potential of pyrophosphate as treatment for vascular calcification in chronic kidney disease patients.
Related Compounds
Related Articles:
2015-04-01
[Mol. Pharmacol. 87(4) , 639-48, (2015)]
2011-10-01
[Planta 234(4) , 657-70, (2011)]
2014-12-01
[Mater. Sci. Eng. C. Mater. Biol. Appl. 45 , 277-86, (2014)]
Long-Term In Vitro Degradation of a High-Strength Brushite Cement in Water, PBS, and Serum Solution.
2015-01-01
[Biomed Res. Int. 2015 , 575079, (2015)]
Removal of sidebands in double-rotation NMR in real time.
[J. Magn. Reson. 211(2) , 234-9, (2011)]